CCM
FLGT icon

Coldstream Capital Management’s Fulgent Genetics FLGT Stock Holding History

Coldstream Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-311
Closed -$5.26K – 1878
2025
Q1 		$5.26K Buy
+311
New +$5.3K ﹤0.01% 2674

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Coldstream Capital Management's FLGT Position: Q2 2025 in Review

Coldstream Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2025, closing a stake of 311 shares — an estimated $5.26K sold.

Coldstream Capital Management first reported a position in FLGT in Q1 2025 and held it in 1 quarter. The position peaked at $5.26K in Q1 2025. 167 funds tracked by Wall St. Rank hold FLGT as of Q2 2025.

  • Coldstream Capital Management reported no remaining Fulgent Genetics position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 311 Fulgent Genetics shares in Q2 2025, an estimated $5.26K.
  • Coldstream Capital Management first reported a position in Fulgent Genetics in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Fulgent Genetics position peaked at $5.26K in Q1 2025.
  • 167 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.